Development of HER2 antigen-degrading Trastuzumab and the immunological and biochemical features.

○Emi Hifumi

11:33 AM - 11:45 AM

[30-211-am15] Development of HER2 antigen-degrading Trastuzumab and the immunological and biochemical features.

○Emi Hifumi^1,2, Moe Tsujita³, Hiroaki Taguchi⁴, Taizo Uda^1,5 (1. Institute for Research Management, Oita University, 2. Research Center for GLOBAL LOCAL Infectious Diseases, Oita University, 3. Graduate School, Oita University, 4. Suzuka University of Medical Science, 5. Information Technologies, and Nanotechnologies (ISIT))

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Presentation information

[30-211-am] Biomolecules /Others

[30-211-am15] Development of HER2 antigen-degrading Trastuzumab and the immunological and biochemical features.

Password